PD-1 is upregulated on CD4+ T cells in patients with SSc, particularly within the PD-1high CXCR5−HLA–DR+ICOS− subset, which is associated with disease activity and severity of ILD.18 This evidence concerns the gene CD4 and systemic sclerosis.